Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · IEX Real-Time Price · USD
6.61
+0.21 (3.28%)
At close: May 1, 2024, 4:00 PM
6.89
+0.28 (4.24%)
Pre-market: May 2, 2024, 4:28 AM EDT
Ardelyx Employees
Ardelyx had 267 employees on December 31, 2023. The number of employees increased by 134 or 100.75% compared to the previous year.
Employees
267
Change (1Y)
134
Growth (1Y)
100.75%
Revenue / Employee
$466,127
Profits / Employee
-$247,442
Market Cap
1.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 267 | 134 | 100.75% |
Dec 31, 2022 | 133 | 47 | 54.65% |
Dec 31, 2021 | 86 | -43 | -33.33% |
Dec 31, 2020 | 129 | 41 | 46.59% |
Dec 31, 2019 | 88 | 2 | 2.33% |
Dec 31, 2018 | 86 | 11 | 14.67% |
Dec 31, 2017 | 75 | -18 | -19.35% |
Dec 31, 2016 | 93 | 32 | 52.46% |
Dec 31, 2015 | 61 | 27 | 79.41% |
Dec 31, 2014 | 34 | 20 | 142.86% |
Dec 31, 2013 | 14 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
Veracyte | 815 |
ADMA Biologics | 624 |
InMode | 581 |
Dynavax Technologies | 408 |
Day One Biopharmaceuticals | 155 |
Kura Oncology | 142 |
Neumora Therapeutics | 124 |
ARDX News
- 20 hours ago - Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings - GlobeNewsWire
- 4 weeks ago - Ardelyx, Inc. Reports Employment Inducement Grants - GlobeNewsWire
- 5 weeks ago - Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy - GlobeNewsWire
- 2 months ago - Ardelyx to Participate at the Cowen 44th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 - GlobeNewsWire
- 4 months ago - Ardelyx stock: Is ARDX a good buy after the 1,360% surge? - Invezz
- 4 months ago - Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities - GlobeNewsWire